ZITHROMAC

Zithromac Adverse Events Reported to the FDA Over Time

How are Zithromac adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Zithromac, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Zithromac is flagged as the suspect drug causing the adverse event.

Most Common Zithromac Adverse Events Reported to the FDA

What are the most common Zithromac adverse events reported to the FDA?

Diarrhoea	40 (4.2%)
Loss Of Consciousness	20 (2.1%)
Rhabdomyolysis	20 (2.1%)
Stevens-johnson Syndrome	20 (2.1%)
Nausea	17 (1.78%)
Pyrexia	17 (1.78%)
Vomiting	17 (1.78%)
Abdominal Pain	15 (1.57%)
Pneumonia	15 (1.57%)
Haematuria	14 (1.47%)
Hepatic Function Abnormal	13 (1.36%)
	Show More
Hypoaesthesia	12 (1.26%)
Oedema	12 (1.26%)
Altered State Of Consciousness	11 (1.15%)
Malaise	11 (1.15%)
Tremor	11 (1.15%)
White Blood Cell Count Decreased	11 (1.15%)
Headache	10 (1.05%)
Rash	10 (1.05%)
Shock	10 (1.05%)
Cardiac Failure	9 (.94%)
Chills	9 (.94%)
Arthralgia	8 (.84%)
Chest Discomfort	8 (.84%)
Dyspnoea	8 (.84%)
Feeling Abnormal	8 (.84%)
Interstitial Lung Disease	8 (.84%)
Palpitations	8 (.84%)
Renal Failure Acute	8 (.84%)
Stomatitis	8 (.84%)
Anaemia	7 (.73%)
Blood Creatine Phosphokinase Increa...	7 (.73%)
Dysgeusia	7 (.73%)
Hypothermia	7 (.73%)
Liver Disorder	7 (.73%)
Myalgia	7 (.73%)
Anaphylactic Shock	6 (.63%)
Depressed Level Of Consciousness	6 (.63%)
Disseminated Intravascular Coagulat...	6 (.63%)
Drug Interaction	6 (.63%)
Face Oedema	6 (.63%)
Chromaturia	5 (.52%)
Decreased Appetite	5 (.52%)
Diarrhoea Haemorrhagic	5 (.52%)
Enterocolitis Haemorrhagic	5 (.52%)
International Normalised Ratio Incr...	5 (.52%)
Oculomucocutaneous Syndrome	5 (.52%)
Peripheral Coldness	5 (.52%)
Platelet Count Increased	5 (.52%)
Abnormal Behaviour	4 (.42%)
Alanine Aminotransferase Increased	4 (.42%)
Anticonvulsant Drug Level Increased	4 (.42%)
Aspartate Aminotransferase Increase...	4 (.42%)
Asthenia	4 (.42%)
Blast Cell Crisis	4 (.42%)
Colitis Ischaemic	4 (.42%)
Deafness	4 (.42%)
Death	4 (.42%)
Delirium	4 (.42%)
Drug Eruption	4 (.42%)
Drug Exposure During Pregnancy	4 (.42%)
Eosinophilic Pneumonia	4 (.42%)
Epistaxis	4 (.42%)
Eye Haemorrhage	4 (.42%)
Gait Disturbance	4 (.42%)
Haematochezia	4 (.42%)
Histiocytosis Haematophagic	4 (.42%)
Hyperglycaemia	4 (.42%)
Hypersensitivity	4 (.42%)
Intraocular Pressure Increased	4 (.42%)
Multi-organ Failure	4 (.42%)
Ocular Hyperaemia	4 (.42%)
Pancytopenia	4 (.42%)
Parosmia	4 (.42%)
Platelet Count Decreased	4 (.42%)
Acute Generalised Exanthematous Pus...	3 (.31%)
Arthritis	3 (.31%)
Blood Bilirubin Increased	3 (.31%)
Cardiac Arrest	3 (.31%)
Cardiac Failure Acute	3 (.31%)
Cholangitis	3 (.31%)
Delusion	3 (.31%)
Dizziness	3 (.31%)
Drug Ineffective	3 (.31%)
Duodenal Stenosis	3 (.31%)
Faeces Discoloured	3 (.31%)
Gastroenteritis	3 (.31%)
Gastrointestinal Inflammation	3 (.31%)
Glossodynia	3 (.31%)
Granulocytopenia	3 (.31%)
Hypoaesthesia Facial	3 (.31%)
Hypoaesthesia Oral	3 (.31%)
Mallory-weiss Syndrome	3 (.31%)
Mouth Ulceration	3 (.31%)
Pain	3 (.31%)
Respiratory Arrest	3 (.31%)
Toxic Epidermal Necrolysis	3 (.31%)
Varicella	3 (.31%)
Visual Field Defect	3 (.31%)
Abdominal Pain Upper	2 (.21%)
Acute Respiratory Failure	2 (.21%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Zithromac, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Zithromac is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Zithromac

What are the most common Zithromac adverse events reported to the FDA?

Neurological	71 (7.45%)
Epidermal And Dermal Conditions	59 (6.19%)
Gastrointestinal Signs	56 (5.88%)
Gastrointestinal Motility And Defec...	45 (4.72%)
Infections - Pathogen Unspecified	34 (3.57%)
Hematology Investigations	30 (3.15%)
Hepatic And Hepatobiliary	30 (3.15%)
Muscle	30 (3.15%)
Body Temperature Conditions	26 (2.73%)
Oral Soft Tissue Conditions	23 (2.41%)
Respiratory	22 (2.31%)
	Show More
Urinary Tract Signs	22 (2.31%)
Gastrointestinal Inflammatory Condi...	17 (1.78%)
Lower Respiratory Tract Disorders	16 (1.68%)
Movement Disorders	14 (1.47%)
Hepatobiliary	13 (1.36%)
Renal Disorders	13 (1.36%)
Allergic Conditions	12 (1.26%)
Heart Failures	12 (1.26%)
Anemias Nonhemolytic And Marrow Dep...	11 (1.15%)
Decreased And Nonspecific Blood Pre...	11 (1.15%)
Joint	11 (1.15%)
Headaches	10 (1.05%)
Therapeutic And Nontherapeutic Effe...	10 (1.05%)
Viral Infectious	10 (1.05%)
Gastrointestinal Hemorrhages	9 (.94%)
White Blood Cell	9 (.94%)
Cardiac Disorder Signs	8 (.84%)
Enzyme	8 (.84%)
Ocular Infections, Irritations And ...	8 (.84%)
Appetite And General Nutritional	7 (.73%)
Cardiac Arrhythmias	7 (.73%)
Chemical Injury And Poisoning	7 (.73%)
Disturbances In Thinking	7 (.73%)
Seizures	7 (.73%)
Cardiac And Vascular Investigations	6 (.63%)
Coagulopathies And Bleeding Diathes...	6 (.63%)
Cranial Nerve Disorders	6 (.63%)
Deliria	6 (.63%)
Glucose Metabolism Disorders	6 (.63%)
Musculoskeletal And Connective Tiss...	6 (.63%)
Tongue Conditions	6 (.63%)
Anxiety Disorders	5 (.52%)
Arteriosclerosis, Stenosis, Vascula...	5 (.52%)
Electrolyte And Fluid Balance Condi...	5 (.52%)
Gastrointestinal Stenosis And Obstr...	5 (.52%)
Suicidal And Self-injurious Behavio...	5 (.52%)
Toxicology And Therapeutic Drug Mon...	5 (.52%)
Cardiac And Vascular Disorders Cong...	4 (.42%)
Coronary Artery	4 (.42%)
Fatal Outcomes	4 (.42%)
Gastrointestinal Ulceration And Per...	4 (.42%)
Hearing	4 (.42%)
Hematopoietic Neoplasms	4 (.42%)
Leukemias	4 (.42%)
Medication Errors	4 (.42%)
Neurological, Special Senses And Ps...	4 (.42%)
Ocular Hemorrhages And Vascular	4 (.42%)
Pleural	4 (.42%)
Psychiatric And Behavioural Symptom...	4 (.42%)
Renal And Urinary Tract Investigati...	4 (.42%)
Upper Respiratory Tract Disorders	4 (.42%)
Bacterial Infectious	3 (.31%)
Bile Duct	3 (.31%)
Neurological Disorders Of The Eye	3 (.31%)
Vision	3 (.31%)
Vulvovaginal Disorders	3 (.31%)
Administration Site Reactions	2 (.21%)
Central Nervous System Infections A...	2 (.21%)
Central Nervous System Vascular	2 (.21%)
Dementia And Amnestic Conditions	2 (.21%)
Eating Disorders	2 (.21%)
Eye	2 (.21%)
Hemolyses And Related Conditions	2 (.21%)
Hypothalamus And Pituitary Gland	2 (.21%)
Immune	2 (.21%)
Inner Ear And Viiith Cranial Nerve	2 (.21%)
Mental Impairment	2 (.21%)
Myocardial	2 (.21%)
Nephropathies	2 (.21%)
Ocular Neuromuscular	2 (.21%)
Physical Examination Topics	2 (.21%)
Protozoal Infectious	2 (.21%)
Skin Appendage Conditions	2 (.21%)
Abortions And Stillbirth	1 (.1%)
Cardiac Valve	1 (.1%)
Cognitive And Attention Disorders	1 (.1%)
Connective Tissue Disorders	1 (.1%)
Depressed Mood Disorders	1 (.1%)
Encephalopathies	1 (.1%)
Gallbladder	1 (.1%)
Glaucoma And Ocular Hypertension	1 (.1%)
Injuries	1 (.1%)
Metabolic, Nutritional And Blood Ga...	1 (.1%)
Mood Disorders	1 (.1%)
Protein And Chemistry Analyses	1 (.1%)
Psychiatric	1 (.1%)
Skin Vascular Abnormalities	1 (.1%)
Sleep Disorders	1 (.1%)
Vascular	1 (.1%)
Vascular Hemorrhagic	1 (.1%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Zithromac, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Zithromac is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.